{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:08:28Z","timestamp":1785812908842,"version":"3.56.0"},"reference-count":37,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.3201\/eid2804.211831","type":"journal-article","created":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T13:37:21Z","timestamp":1648906641000},"source":"Crossref","is-referenced-by-count":17,"title":["Unique Clinical, Immune, and Genetic Signature in Patients with Borrelial Meningoradiculoneuritis1"],"prefix":"10.3201","volume":"28","author":[{"given":"Katarina","family":"Ogrinc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio A.","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi\u0161a","family":"Korva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Bogovi\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Rojko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Lusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geena","family":"Chiumento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franc","family":"Strle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemen","family":"Strle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2804.211831-202204020930-R1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","article-title":"Lyme borreliosis.","volume":"379","author":"Stanek","year":"2012","journal-title":"Lancet"},{"key":"key-10.3201\/eid2804.211831-202204020930-R2","doi-asserted-by":"publisher","first-page":"16090","DOI":"10.1038\/nrdp.2016.90","article-title":"Lyme borreliosis.","volume":"2","author":"Steere","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"key-10.3201\/eid2804.211831-202204020930-R3","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/cid\/ciw299","article-title":"Course and outcome of early European Lyme neuroborreliosis (Bannwarth syndrome): clinical and laboratory findings.","volume":"63","author":"Ogrinc","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2804.211831-202204020930-R4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/femsre\/fux047","article-title":"Lyme borreliosis-from tick bite to diagnosis and treatment.","volume":"42","author":"Stanek","year":"2018","journal-title":"FEMS Microbiol Rev"},{"key":"key-10.3201\/eid2804.211831-202204020930-R5","doi-asserted-by":"crossref","unstructured":"Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010;17:8\u201316, e1\u20134.","DOI":"10.1111\/j.1468-1331.2009.02862.x"},{"key":"key-10.3201\/eid2804.211831-202204020930-R6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/cid\/cit317","article-title":"Suspected early Lyme neuroborreliosis in patients with erythema migrans.","volume":"57","author":"Ogrinc","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2804.211831-202204020930-R7","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3201\/eid2205.151806","article-title":"Differences in genotype, clinical features, and inflammatory potential of Borrelia burgdorferi sensu stricto strains from Europe and the United States.","volume":"22","author":"Cerar","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2804.211831-202204020930-R8","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.semarthrit.2018.09.007","article-title":"Characteristics and clinical outcomes after treatment of a national cohort of PCR-positive Lyme arthritis.","volume":"48","author":"Grillon","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"key-10.3201\/eid2804.211831-202204020930-R9","doi-asserted-by":"publisher","first-page":"e25998","DOI":"10.1371\/journal.pone.0025998","article-title":"TLR1\/TLR2 heterodimers play an important role in the recognition of Borrelia spirochetes.","volume":"6","author":"Oosting","year":"2011","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2804.211831-202204020930-R10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1056\/NEJM199007263230402","article-title":"Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles.","volume":"323","author":"Steere","year":"1990","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2804.211831-202204020930-R11","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1084\/jem.20052471","article-title":"Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide.","volume":"203","author":"Steere","year":"2006","journal-title":"J Exp Med"},{"key":"key-10.3201\/eid2804.211831-202204020930-R12","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/art.34383","article-title":"Association of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis.","volume":"64","author":"Strle","year":"2012","journal-title":"Arthritis Rheum"},{"key":"key-10.3201\/eid2804.211831-202204020930-R13","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41584-021-00648-5","article-title":"Lyme arthritis: linking infection, inflammation and autoimmunity.","volume":"17","author":"Lochhead","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"key-10.3201\/eid2804.211831-202204020930-R14","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/art.34386","article-title":"The Toll of a TLR1 polymorphism in lyme disease: a tale of mice and men.","volume":"64","author":"Sellati","year":"2012","journal-title":"Arthritis Rheum"},{"key":"key-10.3201\/eid2804.211831-202204020930-R15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/cid\/ciy019","article-title":"Neuroimmunomodulators in neuroborreliosis and Lyme encephalopathy.","volume":"67","author":"Eckman","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2804.211831-202204020930-R16","doi-asserted-by":"publisher","first-page":"101390","DOI":"10.1016\/j.ttbdis.2020.101390","article-title":"Cytokines and chemokines in cerebrospinal fluid in relation to diagnosis, clinical presentation and recovery in children being evaluated for Lyme neuroborreliosis.","volume":"11","author":"Skogman","year":"2020","journal-title":"Ticks Tick Borne Dis"},{"key":"key-10.3201\/eid2804.211831-202204020930-R17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1742-2094-8-36","article-title":"Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study.","volume":"8","author":"Henningsson","year":"2011","journal-title":"J Neuroinflammation"},{"key":"key-10.3201\/eid2804.211831-202204020930-R18","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.ttbdis.2018.04.008","article-title":"CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA.","volume":"9","author":"Markowicz","year":"2018","journal-title":"Ticks Tick Borne Dis"},{"key":"key-10.3201\/eid2804.211831-202204020930-R19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1742-2094-11-103","article-title":"CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.","volume":"11","author":"Hyt\u00f6nen","year":"2014","journal-title":"J Neuroinflammation"},{"key":"key-10.3201\/eid2804.211831-202204020930-R20","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1093\/cid\/ciaa337","article-title":"Diagnostic utility of CXCL13 in Lyme neuroborreliosis.","volume":"72","author":"Strle","year":"2021","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2804.211831-202204020930-R21","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s10096-017-3049-x","article-title":"The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children.","volume":"36","author":"Skogman","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key-10.3201\/eid2804.211831-202204020930-R22","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/apm.12596","article-title":"Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis.","volume":"124","author":"Henningsson","year":"2016","journal-title":"APMIS"},{"key":"key-10.3201\/eid2804.211831-202204020930-R23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jinf.2010.11.005","article-title":"Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.","volume":"62","author":"Tjernberg","year":"2011","journal-title":"J Infect"},{"key":"key-10.3201\/eid2804.211831-202204020930-R24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/1471-2334-12-344","article-title":"CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings.","volume":"12","author":"Borde","year":"2012","journal-title":"BMC Infect Dis"},{"key":"key-10.3201\/eid2804.211831-202204020930-R25","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1007\/s00415-008-0974-8","article-title":"CSF B - lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.","volume":"255","author":"Lj\u00f8stad","year":"2008","journal-title":"J Neurol"},{"key":"key-10.3201\/eid2804.211831-202204020930-R26","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.cmi.2018.04.007","article-title":"Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis.","volume":"24","author":"Rupprecht","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid2804.211831-202204020930-R27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1469-0691.2010.03175.x","article-title":"Lyme borreliosis: clinical case definitions for diagnosis and management in Europe.","volume":"17","author":"Stanek","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid2804.211831-202204020930-R28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","article-title":"Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs.","volume":"184","author":"Reiber","year":"2001","journal-title":"J Neurol Sci"},{"key":"key-10.3201\/eid2804.211831-202204020930-R29","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1099\/00207713-44-4-743","article-title":"Diversity of Borrelia burgdorferi sensu lato evidenced by restriction fragment length polymorphism of rrf (5S)-rrl (23S) intergenic spacer amplicons.","volume":"44","author":"Postic","year":"1994","journal-title":"Int J Syst Bacteriol"},{"key":"key-10.3201\/eid2804.211831-202204020930-R30","first-page":"544","article-title":"Characterization of Borrelia burgdorferi sensu lato strains isolated from human material in Slovenia.","volume":"114","author":"Ruzi\u0107-Sablji\u0107","year":"2002","journal-title":"Wien Klin Wochenschr"},{"key":"key-10.3201\/eid2804.211831-202204020930-R31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.resmic.2008.05.005","article-title":"Characterization of Borrelia burgdorferi sensu lato isolates by pulsed-field gel electrophoresis after MluI restriction of genomic DNA.","volume":"159","author":"Ruzi\u0107-Sablji\u0107","year":"2008","journal-title":"Res Microbiol"},{"key":"key-10.3201\/eid2804.211831-202204020930-R32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12974-017-0789-6","article-title":"Intrathecal Th17- and B cell-associated cytokine and chemokine responses in relation to clinical outcome in Lyme neuroborreliosis: a large retrospective study.","volume":"14","author":"Gyllemark","year":"2017","journal-title":"J Neuroinflammation"},{"key":"key-10.3201\/eid2804.211831-202204020930-R33","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1093\/cid\/ciaa335","article-title":"Specificity and diagnostic utility of cerebrospinal fluid CXCL13 in Lyme neuroborreliosis.","volume":"72","author":"Eckman","year":"2021","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2804.211831-202204020930-R34","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1128\/CVI.00353-13","article-title":"Diagnostic value of cytokines and chemokines in lyme neuroborreliosis.","volume":"20","author":"Cerar","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"key-10.3201\/eid2804.211831-202204020930-R35","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1002\/eji.200737034","article-title":"A common human TLR1 polymorphism regulates the innate immune response to lipopeptides.","volume":"37","author":"Hawn","year":"2007","journal-title":"Eur J Immunol"},{"key":"key-10.3201\/eid2804.211831-202204020930-R36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1042\/CS20070214","article-title":"Toll-like receptor polymorphisms and susceptibility to human disease.","volume":"114","author":"Misch","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"key-10.3201\/eid2804.211831-202204020930-R37","doi-asserted-by":"publisher","first-page":"7520","DOI":"10.4049\/jimmunol.178.12.7520","article-title":"Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy.","volume":"178","author":"Johnson","year":"2007","journal-title":"J Immunol"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/28\/4\/21-1831_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:55:22Z","timestamp":1732989322000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/28\/4\/21-1831_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2804.211831","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}